Controlled release formulation of divalproex sodium

Details for Australian Patent Application No. 2004210543 (hide)

Owner Abbott Laboratories

Inventors Engh, Kevin R.; Bollinger, J. Daniel; Cheskin, Howard S.; Poska, Richard P.; Qui, Yihong

Agent Spruson & Ferguson

Pub. Number AU-A-2004210543

Parent 24789

Filing date 9 September 2004

Wipo publication date 7 October 2004

International Classifications

A61K 009/22 Medicinal preparations characterised by special physical form - Sustained or differential release type

A61P 025/08 Drugs for disorders of the nervous system

A61K 031/16 - Amides, e.g. hydroxamic acids

A61K 031/19

A61K 009/16 Medicinal preparations characterised by special physical form - Agglomerates

Event Publications

23 September 2004 Complete Application Filed

7 October 2004 Application Open to Public Inspection

  Published as AU-A-2004210543

27 July 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004210544-Dosage form, device and methods of treatment

2004210542-Dosage form, device and methods of treatment